Acuity Brands INC ACUITY BRANDS O.../ US00508Y1029 /
23/08/2021 00:00:00 | Chg. - | Volume | Bid06:00:04 | Ask06:00:04 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
182.48USD | - | 2 Turnover: - |
-Bid Size: - | -Ask Size: - | 7.91 bill.USD | 0.20% | 23.62 |
GlobeNewswire
08/06
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire
06/06
Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at Re...
GlobeNewswire
05/06
Equip’s Second Annual Report Highlights First-Rate Patient Outcomes, Company Growth
GlobeNewswire
30/05
Newton Golf Shafts Introduces a Weekly Motion Driver Performance Pool Program for PGA TOUR Champions...
GlobeNewswire
29/05
AREX Capital Management Issues Letter to Enhabit Stockholders Regarding the Need for Dramatic Change...
GlobeNewswire
28/05
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
21/05
Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients w...
GlobeNewswire
15/05
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
GlobeNewswire
15/05
Wondr Health and Solera Health Partner to Provide Expert Weight and Obesity-Management Solution for ...
GlobeNewswire
14/05
Parity Healthcare Analytics, Maine RMOMS Network launch program to support state’s obstetrical units
GlobeNewswire
14/05
Western University’s Faculty of Engineering Embraces Holistic Admissions with Acuity Insights’ Caspe...
GlobeNewswire
14/05
Newton Golf Shafts Helps Propel Doug Barron to His First Major Championship on the PGA TOUR Champion...
GlobeNewswire
14/05
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13/05
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GlobeNewswire
10/05
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire
09/05
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update